I do not have any disclosures

Similar documents
FTD basics! Etienne de Villers-Sidani, MD!

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

2016 Programs & Information

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

! slow, progressive, permanent loss of neurologic function.

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Form D1: Clinician Diagnosis

Differential Diagnosis of Hypokinetic Movement Disorders

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Dementia Past, Present and Future

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

Frontotemporal dementia:

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Aging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain:

Biomarkers: Translating Research into Clinical Practice

Confronting the Clinical Challenges of Frontotemporal Dementia

FTD/PPA Caregiver Education Conference March 11, 2011

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

Clinical phenotypes in autopsy-confirmed Pick disease

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

FRONTO TEMPORAL DEMENTIA

FRONTO TEMPORAL DEMENTIA

Frontal Behavioural Inventory (FBI)

Phenotypic Variability in ALS

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

FTD: Improving Outcomes & Outreach

Overview of the non-alzheimer Dementias

Dementia and Aphasia-AD, FTD & aphasia

Differential Diagnosis

Non Alzheimer Dementias

Behavioural variant frontotemporal dementia with dominant gait disturbances case report

Presenter Disclosure Information. I have no financial relationships to disclose:

DEMENTIA ANDREA BERG, MD

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY

Navigating The Cognitive Internet: Introduction. Wendy Lemere DNP, GNP-BC Gerontological Nurse Practitioner Henry Ford Health System

Dr Fiona Kumfor University of Sydney

Objectives. Overview. Why FTD and AD? FTD May Mimic AD. Introduction and Process Norman L. Foster, MD. Introduction and Process 7BS.

ALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide

Common Forms of Dementia Handout Package

Prof Tim Anderson. Neurologist University of Otago Christchurch

Sandra Weintraub, PhD Clinical Core Leader and Professor

What is frontotemporal dementia?

Define functional MRI. Briefly describe fmri image acquisition. Discuss relative functional neuroanatomy. Review clinical applications.

P20.2. Characteristics of different types of dementia and challenges for the clinician

Overview of neurological changes in Alzheimer s disease. Eric Karran

The Person: Dementia Basics

Does corticobasal degeneration exist? A clinicopathological re-evaluation

Diagnosing Dementia: Signs & symptoms, differential diagnosis of common dementias, and non-degenerative memory loss

What is. frontotemporal. address? dementia?

Screening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive Examination

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

What is frontotemporal dementia (FTD)?

ALS and Frontotemporal Dementia. Catherine Lomen-Hoerth, MD, PhD Professor of Neurology University of California, San Francisco

8/24/18. Dementia. Risk of Dementia Following Traumatic Brain Injury: A Review of the Literature. Media Presence. Media Presence

The ABCs of Dementia Diagnosis

Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Frontotemporal Degeneration

ORIGINAL CONTRIBUTION. Dysphagia in Patients With Frontotemporal Lobar Dementia

Form A3: Subject Family History

Title: Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID)

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2

For carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

Neuro degenerative PET image from FDG, amyloid to Tau

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center

Mild Cognitive Impairment (MCI)

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

THIRUVANANTHAPURAM, KERALA

Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Examination of lalopathy and cognitive function in Parkinson's disease-associated diseases

A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies

Frontotemporal Degeneration

LEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders

ORIGINAL CONTRIBUTION. Clinically Undetected Motor Neuron Disease in Pathologically Proven Frontotemporal Lobar Degeneration With Motor Neuron Disease

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center

The prevalence of YOD increases almost exponentially with age (as does the prevalence of late onset dementia).

Frontotemporal Dementia

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech

Lecture 42: Final Review. Martin Wessendorf, Ph.D.

doi: /brain/awr198 Brain 2011: 134;

Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

Disorders of language and speech. Samuel Komoly MD PhD DHAS Professor and Chairman Department of Neurology

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea

Clinical Genetics & Dementia

What is primary progressive aphasia?

EARLY ONSET FRONTOTERMPORAL DEMENTIA AND ALZHEIMERS DISEASE: DIAGNOSIS, TREATMENT AND CARE

What s New in Dementia?

Transcription:

Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo Clinic

I do not have any disclosures

Learning Objectives To be able to recognize 3 clinical FTD syndromes & differentiate them from Alzheimer s dementia To understand how and why FTD is related to progressive e supranuclear palsy, corticobasal degeneration and motor neuron disease

Outline Three clinical FTD syndromes Behavioral variant FTD Semantic Dementia Progressive non-fluent aphasia Three related disorders Progressive supranuclear palsy Corticobasal degeneration Motor neuron disease

Frontotemporal Dementia (FTD) vs. Alzheimer s Disease (AD) Clinical FTD Personality and language AD Episodic memory Neuropsychology Imaging Pathology Executive & Recall & language spatial/perceptual dysfunction Frontal & Mesial temporal anterior lobe & temporal lobes temporoparietal TDP-43 or tau Beta-amyloid amyloid

FTD Over-arching term that encompasses 3 syndromes: Behavioral variant FTD (bvftd) Semantic Dementia (SD) Progressive non-fluent aphasia (PNFA) Characterized by varying degree of personality & behavioral changes and language impairment Neary et al. Neurology 1998

bvftd Clinical Insidious onset & gradual progression Personality and behavioral changes Impairment in personal conduct Loss of emotional responses Mental rigidity Apathy or disinhibition Reduced attention & easily distractible Hyperoral and dietary changes Utilization behavior

Miller et al. Neurology 2007

bvftd Clinical Language impairment can occur (dynamic aphasia), less prominent and occurs later in the disease course Stereotypies occur in up to 60% of patients with bvftd Compulsive type behaviors can be a presenting feature in up to 40% of bvftd patients Mendez et al. J Geriatr Psy N 1997; Josephs et al. Neurobiol Aging 2008

bvftd Imaging g (MRI)

bvftd Imaging g (FDG PET)

Porter et al. Eur J of Neurol 2007

bvftd Neuropsychology Poor performance on test of executive function and behavior Better performance on tests of episodic memory (especially recognition type tests) Relatively normal performance on test of visuospatial/perceptual function

SD Clinical Insidious onset & gradual progression Fluent spontaneous somewhat empty speech Loss of word meaning manifested by impaired naming and comprehension Semantic paraphasias (banana for peach) Surface dyslexia (is land for island)

SD Clinical Behavioral changes can occur but tend to be later in the disease course and are more common when the right anterior temporal lobe is affected. Loss of object and face recognition also can occur especially when right temporal lobe is affected

SD Imaging g (MRI)

SD Imaging g (FDG PET)

64 y.o. woman presented with loss of recognition of familiar faces

SD Neuropsychology Poor performance on test of naming with failure to recognize the object even when target words are given Relatively better performance on tests of episodic memory Relatively normal performance on test of spatial/perceptual function

PNFA Clinical Insidious onset & gradual progression Agrammatism (I am gone house now for the wife) and telegraphic speech (get passport, need for trip) Majority will also have a motor speech impairment (apraxia of speech) with sound based errors and a non-fluent speech output

PNFA Imaging g (MRI)

PNFA Imaging g (FGD PET)

PNFA Neuropsychology Poor performance on test of naming however the patient will recognize the target words when given Difficulty recognizing syntactically complex sentences Relatively better performance on tests of episodic memory Relatively normal performance on test of spatial/perceptual function

Summary of FTD FTD different from AD Three clinical syndromes bvftd (personality change) SD (loss of meaning for words) PNFA (speech output is not fluent) Classification is based on dominant feature, but features do overlap some

FTD Pathologies bvftd SD PNFA TDP-43 Tau

FTD complex bvftd SD PNFA TDP-43 Tau MND FTLD Pick s PSP CBD

FTD complex bvftd SD PNFA TDP-43 Tau MND FTLD PSP Pick CBD FTD-MND PSP CBD

Related Disorders Progressive supranuclear palsy (PSP) Corticobasal degeneration (CBD) Motor neuron disease (MND)

Clinical features associated with PSP Reptilian stare Difficulty looking up or down Stiffness of neck and trunk muscles Poor balance with lots of falls Some patients also have apathy, mild behavioral changes Subtype present with apraxia of speech Josephs et al., Brain 2007

PSP Imaging g (FDG PET)

Clinical features associated with CBD Difficulty moving one arm or leg due to stiffness (rigidity) and dystonia Limb apraxia & myoclonus Trouble controlling movement of limb, i.e., the limb behaves as if it has a mind of its own (so-called alien limb) Behavioral changes can be prominent Present as PNFA initially

CBD Imaging g (FDG PET)

FTD & MND A subset of patients with bvftd-like features also have clinical and pathological features of MND Predominance of lower MND findings Fasciculations (twitching of muscles) Muscle weakness Muscle wasting Flaccid dysarthria (breathy speech) Mackenzie, et al JNEN 2005

MND Upper motor neuron disease findings also occur and can occur in isolation so call FTD/PLS (can mimic PSP) Clinical findings Bulbar signs (spastic dysarthria - strained speech) Limb spasticity Babinski sign Josephs et al. Neurology 2007

MND If lower motor neuron disease is present, average disease duration about 2.3 years (FTD without MND = 7-15 years) If isolated upper motor neuron disease, disease duration about 4 years Therefore, important to diagnose these MND variants Josephs et al. Neurology 2006 & 2007

bvftd vs. FTD-MND bvftd FTD-MND

Final Summary There is overlapping clinical & pathological l features between FTD (bvftd, SD and PNFA) and (PSP, CBD & MND) This suggest that these diseases share cortical regions of loss and possibly mechanism of neurodegeneration It remains important to keep them separate if important treatment and genetic discoveries are to be made.